As earlier discussed, both benzimidazole and oxazole moieties are very important for the treatment of Alzheimer’s disease, and thus hybrid analogues containing benzimidazole and oxazole moieties were synthesized and evaluated for their in vitro AChE and BuChE and molecular docking studies thereafter. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.